[Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing]

Zhonghua Er Ke Za Zhi. 2004 Dec;42(12):936-9.
[Article in Chinese]

Abstract

Objective: To analyze the mechanisms of macrolide resistance in Streptococcus pneumoniae from children in Beijing.

Methods: The MICs of penicillin and erythromycin were determined by the E-test methods for 200 Streptococcus pneumoniae isolates collected from 2002 to 2003 at Beijing Children's Hospital. MICs of azithrhomycin, clarithromycin, acetylspiramycin and clindamycin for 147 erythromycin-resistant isolates were detected by the agar dilution methods. For phenotyping, macrolide resistance induction tests were used in erythromycin-resistant isolates. PCR was used to determine the presence of the erythromycin-resistant genes.

Results: Of 200 Streptococcus pneumoniae isolates, 89.5% were resistant to erythromycin. In 147 erythromycin-resistant isolates, resistance rates were as follows: azithromycin, 100%; clarithromycin, 100%; acetylspiramycin, 95.2%; and clindamycin, 95.9%. The most common macrolide resistance phenotype was the cMIS phenotype (95.9%), 1.4% had the iMLS phenotype and 2.7% the M phenotype. Erythromycin-resistant isolates were characterized for the underlying resistance genotype, with 79.6% having the ermB genotypes, 17.7% having both ermB and mefA, 2.7% having the mefA, and none having neither ermB nor mefA genotypes.

Conclusions: The rates of carriage of macrolide-resistant Streptococcus pneumoniae by children were high in Beijing during 2002 - 2003. cMLS was the most prevalent phenotype among erythromycin-resistant Streptococcus pneumoniae isolates, and ribosomal modification (ermB gene coded) was the main resistance mechanism against macrolides in Beijing region.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Child
  • China
  • Clarithromycin / pharmacology
  • Clindamycin / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Erythromycin / pharmacology
  • Genotype
  • Humans
  • Macrolides / pharmacology*
  • Microbial Sensitivity Tests
  • Penicillins / pharmacology
  • Phenotype
  • Spiramycin / analogs & derivatives
  • Spiramycin / pharmacology
  • Streptococcal Infections / genetics
  • Streptococcal Infections / microbiology*
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / genetics*
  • Streptococcus pneumoniae / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • Penicillins
  • acetylspiramycin
  • Clindamycin
  • Erythromycin
  • Spiramycin
  • Clarithromycin